Kyntra Bio, Inc. (KYNB) Tops Q2 EPS by 614c

Kyntra Bio, Inc. (NASDAQ: KYNB) reported Q2 EPS of $2.96, $6.14 better than the analyst estimate of ($3.18).

For earnings history and earnings-related data on Kyntra Bio, Inc. (KYNB) click here.

You May Also Be Interested In

• Godaddy Gets Takeover Offer From Gen Digital - FT
• Uxin Limited (UXIN) Reports Q3 EPS of $0.00
• Advanced Energy launches MIL-STD certified 160 W power supply